KATHRYN DAUZAT: Open Payments
NPI 1083986566 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| LEO Pharma Inc. | 1 | $20 |
| TOLMAR, INC. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: RINVOQ, CAPLYTA, VRAYLAR, QULIPTA, VALCHLOR, Kerendia, ANZUPGO, JATENZO.
Industry payments across LA — which companies pay providers there.
